[1]
S. Xiong and G.-M. Zou, “CDK4/6 inhibition in hematologic malignancies: bone marrow protection in chemotherapy and anti-leukemic activity”, Am J Transl Med, vol. 9, no. 3, pp. 101–103, Sep. 2025.